Research Use Disclaimer

This content is provided for educational and informational purposes only. It is not medical advice. All information is presented in a research context.

Semax Dosage & Protocol (Research Use)

This page does not provide dosing instructions. It explains how Semax dosage is typically reported in research papers, and why protocols can’t be copied out of context.

How Protocols Are Reported

Protocol Table

ElementWhat papers reportWhy it varies
Routecontext-dependentmodel and constraints
Schedulecontext-dependentobservation windows
Durationcontext-dependentstudy endpoints

FAQ

Q1: Does this page provide Semax dosage instructions? A1: No. This page is not medical advice and does not provide dose reporting instructions.

Q2: Why does dose reporting vary across studies? A2: Because route, schedule, duration, and endpoints differ across study designs.

Q3: Where can I read Semax side effects? A3: See Semax side effects: /peptides/semax/side-effects/.

References

  1. Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice. *2025 Nov;182(22):5489-5516* (2025). https://pubmed.ncbi.nlm.nih.gov/40692165/ (DOI: https://doi.org/10.1111/bph.70122)
  2. Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats. *2021 Apr:86:102114* (2021). https://pubmed.ncbi.nlm.nih.gov/33418449/ (DOI: https://doi.org/10.1016/j.npep.2020.102114)
  3. Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models. *2022 Feb 16;13(4):486-496* (2022). https://pubmed.ncbi.nlm.nih.gov/35080861/ (DOI: https://doi.org/10.1021/acschemneuro.1c00707)

Internal Links